{
    "Trade/Device Name(s)": [
        "LZI Opiate 2000 Enzyme Immunoassay",
        "LZI Opiate 2000 Enzyme Calibrators",
        "LZI Opiate 2000 Enzyme Controls",
        "LZI Opiate 2000 Drugs of Abuse (DAU) Calibrators",
        "LZI Opiate 2000 Drugs of Abuse (DAU) Controls"
    ],
    "Submitter Information": "Lin-Zhi International, Inc.",
    "510(k) Number": "K120761",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020638",
        "K020769"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "DLJ",
        "LAS"
    ],
    "Summary Letter Date": "April 26, 2012",
    "Summary Letter Received Date": "April 27, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.3650",
        "21CFR862.3200",
        "21CFR862.3280"
    ],
    "Regulation Name(s)": [
        "Opiate Test System",
        "Calibrator, Drug Specific",
        "Control, Drug Specific"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Morphine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Hitachi 717 automated clinical system analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay"
    ],
    "Methodologies": [
        "Enzyme immunoassay (EIA)"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for LZI Opiate 2000 Enzyme Immunoassay, Calibrators and Controls for qualitative and semi-quantitative determination of morphine in urine.",
    "Indications for Use Summary": "Qualitative and semi-quantitative determination of morphine in human urine at a 2000 ng/mL cutoff, for use with automated clinical chemistry analyzers; preliminary analytical result, requires confirmation by GC/MS or LC/MS.",
    "fda_folder": "Toxicology"
}